2 citations
,
August 2022 in “JAAD case reports” This review discusses vaccine safety concerns for individuals with autoimmune and inflammatory conditions, noting vaccine hesitancy due to observed exacerbations post-vaccination and a lack of comprehensive trial data.
4 citations
,
May 2021 in “Journal of The European Academy of Dermatology and Venereology” This study found no significant correlation between androgenetic alopecia or other hyper-androgenic skin manifestations and the severity of COVID-19 outcomes in hospitalized patients.
January 2026 in “Journal of Contemporary Medicine” This narrative review explores mechanisms linking COVID-19 with hair loss, highlighting how cytokine-mediated inflammation, androgen-regulated TMPRSS2 expression, and direct follicular injury contribute to the condition. It suggests that vitamin D could potentially mitigate this hair loss by suppressing inflammation and viral entry, warranting further research.
6 citations
,
May 2022 in “Frontiers in Medicine” This study observed that COVID-19-related stress and fear were potentially associated with an increased occurrence of hair diseases like telogen effluvium, alopecia areata, and seborrheic dermatitis among medical students in Bangladesh.
November 2025 in “Health Promotion Evidence” This study reviewed interventions for post-COVID-19 alopecia and concluded that integrated physiotherapeutic strategies, including photobiomodulation, micro-needling, electrotherapy, and scalp massage, can reduce hair loss and improve hair density, contributing positively to patient quality of life.